Egypt Syringes, Auto Disable Syringe and IV Cannulas Market - Industry Trends and Forecast to 2028

TABLE OF CONTENT

TABLE OF CONTENTS 1 INTRODUCTION 13 1.1 OBJECTIVES OF THE STUDY 13 1.2 MARKET DEFINITION 13 1.3 OVERVIEW OF EGYPT SYRINGES, AUTO DISABLE SYRINGE AND IV CANNULAS MARKET 13 1.4 LIMITATIONS 15 1.5 MARKETS COVERED 16 2 MARKET SEGMENTATION 19 2.1 MARKETS COVERED 19 2.2 GEOGRAPHICAL SCOPE 20 2.3 YEARS CONSIDERED FOR THE STUDY 21 2.4 CURRENCY AND PRICING 21 2.5 DBMR TRIPOD DATA VALIDATION MODEL 22 2.6 MULTIVARIATE MODELLING 25 2.7 TYPE LIFELINE CURVE 26 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 27 2.9 DBMR MARKET POSITION GRID 28 2.10 VENDOR SHARE ANALYSIS 30 2.11 SECONDARY SOURCES 31 2.12 ASSUMPTIONS 31 3 EXECUTIVE SUMMARY 32 4 PREMIUM INSIGHTS 35 4.1 PORTERS 36 4.2 PESTEL FRAMEWORK FOR EGYPT SYRINGES, AUTO DISABLE SYRINGE AND IV CANNULAS MARKET 36 5 EGYPT SYRINGES, AUTO DISABLE SYRINGE AND IV CANNULAS MARKET: REGULATIONS 38 5.1 MEDICAL DEVICES DEFINITION: 39 5.2 MEDICAL DEVICES REGULATIONS: 40 5.3 REQUIRED DOCUMENTATION: 41 5.4 COUNTRY SPECIFICS: 41 5.5 PRE-OWNED MEDICAL DEVICES: 42 6 MARKET OVERVIEW 43 6.1 DRIVERS 45 6.1.1 RISE IN GERIATRIC POPULATION 45 6.1.2 INCREASING PREVALENCE OF CHRONIC DISEASES 46 6.1.3 INCREASE IN THE VOLUME OF VACCINATIONS DUE TO COVID-19 PANDEMIC 46 6.2 RESTRAINTS 47 6.2.1 DEARTH OF SKILLED NURSES 47 6.2.2 STRINGENT REGULATIONS FOR MANUFACTURING AND MARKETING OF SYRINGES, AUTO-DISABLE SYRINGE AND IV CANNULAS 47 6.3 OPPORTUNITIES 48 6.3.1 ORGANIZATION EFFORTS TOWARDS SAFE HEALTHCARE PRACTICES 48 6.3.2 TECHNOLOGICAL ADVANCEMENT IN AUTO-SYRINGE SECTOR 49 6.4 CHALLENGES 49 6.4.1 COST VARIATION IN AUTO-DISABLE SYRINGE AND CANNULAS AS COMPARED TO REGULAR CANNULAS & SYRINGES 49 6.4.2 ENVIRONMENTAL EFFECT OF DISPOSABLE MEDICAL DEVICES 50 7 IMPACT OF COVID-19 ON EGYPT SYRINGES, AUTO DISABLE SYRINGE AND IV CANNULAS MARKET 51 7.1 AFTERMATH OF COVID-19 AND GOVERNMENT ROLE 51 7.2 STRATEGIC DECISIONS FOR MARKET PLAYERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE 51 7.3 IMPACT ON DEMAND 52 7.4 IMPACT ON SUPPLY CHAIN 52 7.5 CONCLUSION 52 8 EGYPT SYRINGES MARKET, BY TYPE 53 8.1 OVERVIEW 53 5.1 GENERAL SYRINGES 55 5.2 SPECIALIZED SYRINGES 55 5.3 SMART SYRINGES 56 9 EGYPT SYRINGES MARKET, BY USAGE 58 9.1 OVERVIEW 58 5.4 REUSABLE SYRINGES 61 5.5 DISPOSABLE SYRINGES 61 10 EGYPT AUTO DISABLE SYRINGE MARKET AND IV CANNULAS MARKET, BY TYPE, 2019-2028 (USD MILLION) 62 10.1 OVERVIEW 62 5.6 AUTO DISABLE SYRINGE 62 5.7 IV CANNULA 64 11 EGYPT AUTO DISABLE SYRINGE MARKET, BY MATERIAL 65 11.1 OVERVIEW 65 5.8 POLYPROPYLENE BARREL 67 5.9 RUBBER PLUNGER 68 5.10 LUBRICANT SILICONE OIL. 68 12 EGYPT AUTO DISABLE SYRINGE MARKET, BY LOCK SYSTEM 69 12.1 OVERVIEW 69 5.11 BARREL SEAL LOCK SYSTEM 71 5.12 TOP PLUNGER LOCK SYSTEM 72 13 EGYPT AUTO DISABLE SYRINGE MARKET, BY VOLUME 73 13.1 OVERVIEW 74 13.2 1 ML 78 13.3 0.5 ML 78 13.4 0.3 ML 78 13.5 0.1 ML 78 13.6 0.05 ML 79 13.7 OTHERS 79 14 EGYPT AUTO DISABLE SYRINGE AND IV CANNULAS MARKET, BY APPLICATION 80 14.1 OVERVIEW 81 14.2 DRUG DELIVERY 84 14.3 FLUIDS 84 14.4 BLOOD COLLECTION 84 14.5 VACCINATION 85 14.6 OTHERS 85 15 EGYPT AUTO DISABLE SYRINGE AND IV CANNULAS MARKET, BY INDICATION 86 15.1 OVERVIEW 87 15.2 INFECTIOUS DISEASES 90 15.3 INFLAMMATORY/AUTO-IMMUNE DISEASES 90 15.4 VACCINES 90 15.5 OTHERS 91 16 EGYPT IV CANNULAS MARKET , BY GAUZE SIZE 92 16.1 OVERVIEW 93 16.2 17G TO 20G 96 16.3 22G TO 26G 96 16.4 14G TO 16G 97 17 EGYPT AUTO DISABLE SYRINGE AND IV CANNULAS MARKET, BY END USER 98 17.1 OVERVIEW 99 17.2 HOPSITALS 102 17.3 CLINICS 102 17.4 AMBULATORY CENTERS 102 17.5 RESEARCH LABORATORIES 103 17.6 OTHERS 103 18 EGYPT AUTO DISABLE SYRINGE AND IV CANNULAS MARKET, BY DISTRIBUTION CHANNEL 104 18.1 OVERVIEW 105 18.2 PHARMACIES 108 18.3 SPECIALTY STORES 108 18.4 ONLINE 108 18.5 OTHERS 109 19 EGYPT IV CANNULAS MARKET, BY IV THERAPY 110 19.1 OVERVIEW 111 19.2 CENTRAL IV CANNULA 113 19.3 MIDLINE IV CANNULA 114 19.4 PERIPHERAL IV CANNULA 114 20 EGYPT SYRINGES, AUTO DISABLE SYRINGE AND IV CANNULAS MARKET: COMPANY LANDSCAPE 115 20.1 COMPANY SHARE ANALYSIS: EGYPT 115 21 SWOT ANALYSIS 116 22 COMPANY PROFILE 117 22.1 BD 117 22.1.1 COMPANY SNAPSHOT 117 22.1.2 REVENUE ANALYSIS 118 22.1.3 PRODUCT PORTFOLIO 118 22.1.4 RECENT DEVELOPMENT 118 22.2 ELARABI PHARMA GROUP 119 22.2.1 COMPANY SNAPSHOT 119 22.2.2 PRODUCT PORTFOLIO 119 22.2.3 RECENT DEVELOPMENT 119 22.3 AMECO 120 22.3.1 COMPANY SNAPSHOT 120 22.3.2 PRODUCT PORTFOLIO 120 22.3.3 RECENT DEVELOPMENT 120 22.4 POLYMEDICURE 121 22.4.1 COMPANY SNAPSHOT 121 22.4.2 PRODUCT PORTFOLIO 121 22.4.3 RECENT DEVELOPMENT 122 22.5 INTERMEDICA.COM.EG 123 22.5.1 COMPANY SNAPSHOT 123 22.5.2 PRODUCT PORTFOLIO 123 22.5.3 RECENT DEVELOPMENT 123 22.6 ADVACARE PHARMA 124 22.6.1 COMPANY SNAPSHOT 124 22.6.2 PRODUCT PORTFOLIO 124 22.6.3 RECENT DEVELOPMENT 124 22.7 DENEX INTERNATIONAL 125 22.7.1 COMPANY SNAPSHOT 125 22.7.2 PRODUCT PORTFOLIO 125 22.7.3 RECENT DEVELOPMENT 125 22.8 ELDAWLIA 126 22.8.1 COMPANY SNAPSHOT 126 22.8.2 PRODUCT PORTFOLIO 126 22.8.3 RECENT DEVELOPMENT 126 22.9 STERIMED GROUP 127 22.9.1 COMPANY SNAPSHOT 127 22.9.2 PRODUCT PORTFOLIO 127 22.9.3 RECENT DEVELOPMENT 127 22.10 ULTRAMEDUMIC 128 22.10.1 COMPANY SNAPSHOT 128 22.10.2 PRODUCT PORTFOLIO 128 22.10.3 RECENT DEVELOPMENTS 128 23 QUESTIONNAIRE 129 24 RELATED REPORTS 134